Why the study?
Overactivity of renal sympathetic nerves and nitric oxide deficiency occur in hypertensive CKD, and it was hypothesized that improved glomerular filtration rate after renal denervation is associated with increased nitric oxide bioavailability.
Does renal denervation improve nitric oxide bioavailability and kidney function in sheep with hypertensive chronic kidney disease?
Does renal denervation improve nitric oxide bioavailability and kidney function in sheep with hypertensive chronic kidney disease?
Renal denervation normalizes nitric oxide bioavailability and restores its contribution to renal hemodynamics in a sheep model of hypertensive CKD.
Answers are grounded in this paper and cite their sources.
Supports RDN restoring NO bioavailability in hypertensive CKD models; leaves open human translation.
Overactivity of renal sympathetic nerves and nitric oxide (NO) deficiency occur in hypertensive chronic kidney disease (CKD). In sheep with hypertensive CKD and NO deficiency, renal denervation (RDN) reduces blood pressure and improves kidney function (glomerular filtration rate). We hypothesized that this improvement in glomerular filtration rate after RDN is associated with increased NO bioavailability. In this study, glomerular filtration rate response to systemic inhibition of NOS (NO synthase) was examined in healthy and CKD sheep at 2 and 30 months after a sham (intact nerves) or RDN procedure. Basal urinary total nitrate (nitrate+nitrite) excretion was examined at 2 and 30 months, and kidney protein expression of endothelial and neuronal NOS was assessed at 30 months. Urinary nitrate+nitrite in CKD-RDN and healthy sheep was ≈50% to 70% greater than in CKD-intact. During NOS inhibition, the fall in glomerular filtration rate in CKD-RDN sheep was ≈20% greater than in CKD-intact. These effects in CKD-RDN sheep were similar to those in healthy sheep. Endothelial NOS protein expression was lower in CKD-intact sheep compared with healthy sheep and compared with CKD-RDN. In summary, RDN normalizes NO bioavailability and restores contribution of NO to renal hemodynamics in CKD. These changes may promote improvements in kidney function and sustained blood pressure lowering after RDN in hypertensive CKD.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: